1-6 of 6
Isabel Poschke
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A036: Combining data-independent acquisition and targeted immunopeptidomics to enhance neoepitope discovery

Jonas P Becker, Jonas D Förster, Sven Blobner, David Weber, Sebastian Uhrig, Annika Baude, Johanna Wagner, Isabel Poschke, Michael Platten, Stefan Fröhling, Peter Horak, Angelika B Riemer
Journal: Cancer Immunology Research
Cancer Immunol Res (2024) 12 (10_Supplement): A036.
https://doi.org/10.1158/2326-6074.TUMIMM24-A036
Published: 18 October 2024
View article titled, Abstract A036: Combining data-independent acquisition and targeted immunopeptidomics to enhance neoepitope discovery
Journal Articles

Abstract B026: MDSCs and CD8 effector memory T cells correlate with survival in melanoma patients treated with ipilimumab

Yago Pico De Coaña, Maria Wolodarski, Isabel Poschke, Yuya Yoshimoto, Giuseppe Masucci, Johan Hansson, Rolf Kiessling
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11_Supplement): B026.
https://doi.org/10.1158/2326-6066.IMM2016-B026
Published: 31 October 2016
View article titled, Abstract B026: MDSCs and CD8 effector memory T cells correlate with survival in melanoma patients treated with ipilimumab
Journal Articles

Abstract A070: Genetic knockdown screens across tumor types unravel a diverse tumor “immune-modulatome” landscape

Nisit Khandelwal, Tillmann Michels, Marco Breinig, Antonio Sorrentino, Isabel Poschke, Rienk Offringa, Michal Lotem, Michael Boutros, Philipp Beckhove
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): A070.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A070
Published: 03 January 2016
View article titled, Abstract A070: Genetic knockdown screens across tumor types unravel a diverse tumor “immune-modulatome” landscape
Journal Articles

Abstract A071: Immune monitoring of ipilimumab treated patients reveals enhanced CD4+ T cell activation correlated with diminished MDSCs

Yago Pico de Coaña, Maria Wolodarski, Yuya Yoshimoto, Giusy Gentilcore, Isabel Poschke, Giuseppe V. Masucci, Johan Hansson, Rolf Kiessling
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): A071.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A071
Published: 03 January 2016
View article titled, Abstract A071: Immune monitoring of ipilimumab treated patients reveals enhanced CD4+ T cell activation correlated with diminished MDSCs
Journal Articles

Abstract IA46: Towards implementation of T-cell therapy in pancreatic cancer

Rienk Offringa, Isabel Poschke, Michael Volkmar, Oliver Strobel, Frank Bergmann, Niels Halama, Dirk Jäger, Ugur Sahin, Markus Büchler
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): IA46.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-IA46
Published: 03 January 2016
View article titled, Abstract IA46: Towards implementation of T-cell therapy in pancreatic cancer
Journal Articles

Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production

Yago Pico de Coaña, Isabel Poschke, Giusy Gentilcore, Yumeng Mao, Maria Nyström, Johan Hansson, Giuseppe V. Masucci, Rolf Kiessling
Journal: Cancer Immunology Research
Cancer Immunol Res (2013) 1 (3): 158–162.
https://doi.org/10.1158/2326-6066.CIR-13-0016
Published: 08 September 2013
View article titled, Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production
Open the PDF for Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production in another window
Includes: Supplementary data